3D Medicines Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was CNY 634.95 million compared to CNY 567.39 million a year ago. Net loss was CNY 524.7 million compared to CNY 1,024.35 million a year ago.

Basic loss per share from continuing operations was CNY 2.3 compared to CNY 22.52 a year ago.